PF-Atlas › Clinical Trials › NCT05626387

An RCT of Mycophenolate Mofetil in Fibrotic Hypersensitivity Pneumonitis

Mycophenolate Mofetil plus prednisolone · Phase 4

Registry ID
NCT05626387
Phase
Phase 4
Status
Active, not recruiting
Drug / intervention
Mycophenolate Mofetil plus prednisolone
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Start
2022-11-23

About this trial

Mycophenolate Mofetil plus prednisolone is evaluated in NCT05626387, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Post Graduate Institute of Medical Education and Research, Chandigarh. Current status: Active, not recruiting.

View NCT05626387 on ClinicalTrials.gov →

Explore related

All Mycophenolate Mofetil plus prednisolone trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT05626387 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.